Healthcare Life Sciences Regulations Telemedicine 
Health Populi
AUGUST 12, 2021
For this annual report, Ordr analyzed security risks across over 500 deployments in healthcare, life sciences, retail, and manufacturing sectors for the 12 months June 2020 through June 2021. What’s unclear is how public policy and regulation can/will meet this moment. How to protect vulnerable groups of people?
Health Populi
JUNE 24, 2021
The economic and healthcare system impacts of this were explored in the Post-Covid Healthcare Landscape , delivered by Fitch Solutions’ Jamie Davies and Beau Noafshar, leaders in the Pharmaceuticals, Healthcare, and Medical Devices groups. PPP in the US), and in emerging markets, currency weakness. spends on NASA.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Lexis Nexis
APRIL 12, 2021
Josh Schoeller, CEO of LexisNexis Risk Solutions Health Care, recently shared industry insights in a candid interview with HIStalk, a healthcare technology industry blog. Leading this business since 2018, Schoeller is responsible for delivering solutions across health plan, hospital and health system, pharmacy, and life science markets.
HIT Consultant
MARCH 31, 2024
Director of Technical Product Management at McKesson Worldwide, today’s leading healthcare organizations are embracing digital transformation. With an eye toward the future, healthcare and life sciences (HLS) organizations integrating CPQ are set to fundamentally alter traditional care delivery and management models.
HIT Consultant
MARCH 9, 2023
Cristina Varner, Newfront, SVP National Life Science & Healthcare Practice Gone are the days when healthcare information was only available to us at the doctor’s office or through the office’s online portals, and that’s in part due to the rapidly growing popularity of wearable technology devices.
HIT Consultant
MAY 31, 2023
Harshit Jain MD, Founder and Global CEO of Doceree Consolidation and the threat of monopolization in healthcare are rising. Monopolistic practices within healthcare and pharmaceutical industries not only hurt a healthy economy, but they also ultimately limit patients’ choices when it comes to healthcare options, further eroding trust.
Lexis Nexis
JANUARY 4, 2022
Healthcare and technology: two words with so much depth and which are synonymous with progress. While there is much unknown about what 2022 will bring, one thing is certain – the healthcare industry will experience exponential advances brought on by rapid innovation in technology and access to the data that underpins it.
Expert insights. Personalized for you.
174 
Let's personalize your content